Ketryx raised a $14 million Series A led by Lightspeed Venture Partners, Medical Design and Outsourcing reported on 5 December 2023. Existing investors MIT’s E14 Fund and Ubiquity Ventures also took part, and a Lightspeed partner was to join the board. The round brought Ketryx’s total funding to more than $18 million.1
The Form D filed with the SEC on 21 December 2023 shows $13,999,977 of equity sold to 5 investors, with the first sale on 6 November 2023.2 Ketryx’s two earlier filings, from 2021 and 2022, show about $2 million each.34 The next round was a $39 million Series B in September 2025 (see our news post).
What it means for buyers
Our Ketryx review notes that Ketryx has never published prices for its paid plans, and that the terms let it raise fees from your next renewal with no cap.
Ketryx: Medtech AI developer Ketryx raises $14M in Series A round led by Lightspeed. Vendor reprint of a Medical Design and Outsourcing article, published 5 Dec 2023, checked 1 Oct 2026. ↩︎
SEC: Ketryx Corp Form D, filed 21 Dec 2023. US public filing, checked 1 Oct 2026. ↩︎
SEC: Ketryx Corp Form D, filed 16 Nov 2021. US public filing, checked 1 Oct 2026. ↩︎
SEC: Ketryx Corp Form D, filed 6 Jul 2022. US public filing, checked 1 Oct 2026. ↩︎
About: Ketryx review